... Firms Focus on Advanced Melanoma
Major pharmaceutical companies are racing to launch breakthrough drugs in the next 18 months to treat advanced melanoma, the deadliest form of skin cancer. Bristol-Myers Squibb Co. BMY -1.94% Bristol-Myers Squibb Co. U.S.: NYSE $ 51.05 -1.01 -1.94% …
Read more on Wall Street Journal
Bill aims to expand conditional licenses for drug offenders
What may have made
The Original Post is Located Here: Latest Online Drug Treatment News
